Independent Advisor Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
2,909
+81
| +3% | +$36.1K | 0.04% | 359 |
|
|
2025
Q1 | $1.37M | Buy |
2,828
+600
| +27% | +$291K | 0.05% | 319 |
|
|
2024
Q4 | $897K | Buy |
2,228
+1,054
| +90% | +$425K | 0.01% | 756 |
|
|
2024
Q3 | $546K | Sell |
1,174
-639
| -35% | -$297K | 0.02% | 445 |
|
|
2024
Q2 | $850K | Buy |
1,813
+430
| +31% | +$202K | 0.03% | 356 |
|
|
2024
Q1 | $578K | Sell |
1,383
-29
| -2% | -$12.1K | 0.02% | 420 |
|
|
2023
Q4 | $575K | Buy |
1,412
+80
| +6% | +$32.6K | 0.02% | 414 |
|
|
2023
Q3 | $463K | Sell |
1,332
-10
| -0.7% | -$3.48K | 0.02% | 426 |
|
|
2023
Q2 | $472K | Buy |
1,342
+139
| +12% | +$48.9K | 0.02% | 441 |
|
|
2023
Q1 | $379K | Buy |
+1,203
| New | +$379K | 0.02% | 474 |
|
|
2022
Q4 | – | Sell |
-1,195
| Closed | -$346K | – | 628 |
|
|
2022
Q3 | $346K | Sell |
1,195
-325
| -21% | -$94.1K | 0.02% | 456 |
|
|
2022
Q2 | $428K | Sell |
1,520
-386
| -20% | -$109K | 0.02% | 411 |
|
|
2022
Q1 | $497K | Buy |
+1,906
| New | +$497K | 0.02% | 397 |
|
|
2021
Q3 | – | Sell |
-1,187
| Closed | -$239K | – | 673 |
|
|
2021
Q2 | $239K | Buy |
1,187
+57
| +5% | +$11.5K | 0.01% | 554 |
|
|
2021
Q1 | $243K | Buy |
1,130
+49
| +5% | +$10.5K | 0.01% | 526 |
|
|
2020
Q4 | $255K | Sell |
1,081
-50
| -4% | -$11.8K | 0.02% | 464 |
|
|
2020
Q3 | $308K | Sell |
1,131
-10,424
| -90% | -$2.84M | 0.02% | 385 |
|
|
2020
Q2 | $3.36M | Buy |
11,555
+10,474
| +969% | +$3.04M | 0.36% | 57 |
|
|
2020
Q1 | $257K | Buy |
+1,081
| New | +$257K | 0.04% | 309 |
|